2Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappinscott HM. Microbial biofilms. Annu Rev Microbiol 1995; 49:711-745.
3Werner E, Roe F, Bugnicourt A, et al. Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2004; 70: 6188-6196.
4Moskowitz SM, WEmerson JC, McNamara S, et al. Rando- mized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection. Pediatr Pulmono12011; 46:18~ 192.
5Herrmann C~ Yang L, Wu H, et al. Colistin-tobramycin combinations are superior to monotherapy conceming killing ofbiofilm Pseudomonas aeruginosa. J lnfect Dis 2010; 202: 1585-1592.
6Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Hoiby N Spread of colistin-resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 2008; 7:391-397.
7Bjamsholt T, Moser C, Jensen PO, Hoiby NE. Biofilm Infections. New York: Springer, 2010.
8Costerton W, Veeh R, Shirtliff M, et al. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003; 112: 1466-1477.
9Bjarnsholt T, Jensen PO, Fiandaca MJ, et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmono12009; 44: 547-558.
10Hoiby N, Bjamsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35: 322-332.
